Abasic site–peptide cross-links are blocking lesions repaired by AP endonucleases
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Anna V Yudkina und 7 weiteren Autor:innen. Beteiligte Einrichtung: SB RAS Institute of Chemical Biology and Fundamental Medicine, Novosibirsk 630090, Russia. Hauptthemen laut MEDLINE: DNA Repair, DNA-(Apurinic or Apyrimidinic Site) Lyase. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Russian Science Foundation, Fondation ARC, Russian Ministry of Higher Education and Science.
Abstract (Originalsprache)
Apurinic/apyrimidinic (AP) sites are abundant DNA lesions arising from spontaneous hydrolysis of the N-glycosidic bond and as base excision repair (BER) intermediates. AP sites and their derivatives readily trap DNA-bound proteins, resulting in DNA–protein cross-links. Those are subject to proteolysis but the fate of the resulting AP–peptide cross-links (APPXLs) is unclear. Here, we report two in vitro models of APPXLs synthesized by cross-linking of DNA glycosylases Fpg and OGG1 to DNA followed by trypsinolysis. The reaction with Fpg produces a 10-mer peptide cross-linked through its N-terminus, while OGG1 yields a 23-mer peptide attached through an internal lysine. Both adducts strongly blocked Klenow fragment, phage RB69 polymerase, Saccharolobus solfataricus Dpo4, and African swine fever virus PolX. In the residual lesion bypass, mostly dAMP and dGMP were incorporated by Klenow and RB69 polymerases, while Dpo4 and PolX used primer/template misalignment. Of AP endonucleases involved in BER, Escherichia coli endonuclease IV and its yeast homolog Apn1p efficiently hydrolyzed both adducts. In contrast, E. coli exonuclease III and human APE1 showed little activity on APPXL substrates. Our data suggest that APPXLs produced by proteolysis of AP site-trapped proteins may be removed by the BER pathway, at least in bacterial and yeast cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- SB RAS Institute of Chemical Biology and Fundamental Medicine, Novosibirsk 630090, Russia.
- Department of Natural Sciences, Novosibirsk State University, Novosibirsk 630090, Russia.
- Groupe "Mechanisms of DNA Repair and Carcinogenesis", Equipe Labellisée LIGUE 2016, CNRS UMR9019, Université Paris-Saclay, Gustave Roussy Cancer Campus, F-94805 Villejuif, France.
ORCID-Profile: Murat K Saparbaev, Dmitry O Zharkov
Förderung
- Russian Science Foundation
- Fondation ARC
- Russian Ministry of Higher Education and Science
- Russian Foundation for Basic Research
Zitieren
APA
Yudkina, A. V., Bulgakov, N. A., Kim, D. V., Baranova, S. V., Ishchenko, A. A., Saparbaev, M. K., Koval, V. V., & Zharkov, D. O. (2023). Abasic site–peptide cross-links are blocking lesions repaired by AP endonucleases. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad423
Vancouver
Yudkina AV, Bulgakov NA, Kim DV, Baranova SV, Ishchenko AA, Saparbaev MK, et al. Abasic site–peptide cross-links are blocking lesions repaired by AP endonucleases. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad423
BibTeX
@article{Yudkina2023,
author = {Yudkina, Anna V and Bulgakov, Nikita A and Kim, Daria V and Baranova, Svetlana V and Ishchenko, Alexander A and Saparbaev, Murat K and Koval, Vladimir V and Zharkov, Dmitry O},
title = {Abasic site–peptide cross-links are blocking lesions repaired by AP endonucleases},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad423}
}
EUVIMED